Low-Dose Chemotherapy in Combination with COX-2 Inhibitors and PPAR-Gamma Agonists in Recurrent High-Grade Gliomas – A Phase II Study

Publisher： Karger

E-ISSN： 1423-0232|73|1-2|21-25

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.1-2, 2008-03, pp. : 21-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 337-342

Karger

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the gastrointestinal benefits of COX‐2 selective inhibitors with concomitant use of low‐dose aspirin

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 785-795

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy: Low-Grade Gliomas of the Hypothalamus and Thalamus

By  

Pediatric Neurosurgery, Vol. 32, Iss. 5, 2000-08 ,pp. : 259-263

Karger

Access to resources Recommend Favorite

Treatment of High-Grade Gliomas in the Elderly

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 307-313

Karger

Access to resources Recommend Favorite